92
Participants
Start Date
June 30, 2013
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Paclitaxel
Ifosfamide
Cisplatin
Mesna
Bleomycin
Etoposide
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Nassau, Uniondale
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack
University of Pittsburgh Medical Center, Pittsburgh
University of North Carolina, Chapel Hill
Mayo Clinic, Rochester
University of Southern California, Los Angeles
Stanford University Medical Center, Stanford
University of Chicago, Chicago
Memorial Sloan Kettering Cancer Center, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen (Follow-up Only), Montvale
Collaborators (1)
University of Southern California
OTHER
Mayo Clinic
OTHER
University of Pittsburgh
OTHER
University of North Carolina
OTHER
University of Chicago
OTHER
Stanford University
OTHER
University of Texas Southwestern Medical Center
OTHER
Memorial Sloan Kettering Cancer Center
OTHER